Publication | Open Access

113 A phase 2 dose-escalation study of albuferon combined with ribavirin in non-responders to prior interferon-based therapy for chronic hepatitis C infection

Dose-escalation StudyA Phase 2HepatologyViral HepatitisAntiviral Drug DevelopmentAntiviral TherapyHepatitisPharmacotherapyAntiviral DrugInterferon-based TherapyMedicine